SCHEMBL17488702

SCHEMBL17488702

Cc1nc2c(F)cc(-c3nc(Nc4ccc([C@H]5CNCCN5)cn4)ncc3F)cc2n1C(C)C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.64
CDK6 Q00534 16/20 0.64
CDK2 P24941 15/20 0.64
CDK1 P06493 13/20 0.64
CDK7 P50613 8/20 0.64
CDK9 P50750 8/20 0.64
CCNB1 P14635 6/20 0.61
CCNE1 P24864 6/20 0.61
CDK5 Q00535 5/20 0.61
CCNA2 P20248 2/20 0.61
CCND3 P30281 2/20 0.61
CIT O14578 1/20 0.61
GAK O14976 1/20 0.61
DYRK3 O43781 1/20 0.61
CCNT1 O60563 1/20 0.61
STK16 O75716 1/20 0.61
CCNK O75909 1/20 0.61
STK10 O94804 1/20 0.61
PRKD3 O94806 1/20 0.61
ABCB11 O95342 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17488829 0.87 CDK4 (0.69) CDK4CDK6CDK2CDK1CDK7
SCHEMBL17488708 0.87 CDK4 (0.64) CDK4CDK6CDK2CDK1CDK7
SCHEMBL18204141 0.86 CDK4 (0.54) CDK4CDK6CDK2CDK1CDK7
SCHEMBL17488684 0.84 CDK4 (0.63) CDK4CDK6CDK2CDK1CDK7
SCHEMBL22004071 0.84 CDK4 (0.63) CDK4CDK6CDK2CDK1CDK7
SCHEMBL22004066 0.84 CDK4 (0.63) CDK4CDK6CDK2CDK1CDK7
SCHEMBL22004914 0.84 CDK4 (0.63) CDK4CDK6CDK2CDK1CDK7
SCHEMBL22004070 0.84 CDK4 (0.63) CDK4CDK6CDK2CDK1CDK7
SCHEMBL22004068 0.84 CDK4 (0.63) CDK4CDK6CDK2CDK1CDK7
SCHEMBL22004067 0.84 CDK4 (0.63) CDK4CDK6CDK2CDK1CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015605-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed